PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin and DSM Nutritional Products Present New Bioavailability Study Results on FloraGLO® Lutein with Actilease® - Kemin Health, L.C. (Kemin), creator of FloraGLO®, will present exciting new research demonstrating the bioavailability of FloraGLO Lutein with Actilease technology
Kemin and DSM Nutritional Products Present New Bioavailability Study Results on FloraGLO® Lutein with Actilease®

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2010/10/21 - Kemin Health, L.C. (Kemin), creator of FloraGLO®, will present exciting new research demonstrating the bioavailability of FloraGLO Lutein with Actilease technology.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Kemin Health, L.C., creator of FloraGLO®, the world’s leading lutein brand, and DSM Nutritional Products, a premium ingredient supplier to producers of foods, beverages, and dietary supplements, will present exciting new research demonstrating the bioavailability of FloraGLO Lutein with Actilease technology. The importance of using ingredients with clinically proven benefits as a common sense “insurance policy” to maintain a manufacturer’s brand equity and reputation will also be discussed.

At the SupplySide West Expo in Las Vegas, NV, new research will be introduced demonstrating why all lutein ingredients are not the same. Kemin Technical Services Manager, Diane Alexander, Ph.D., and DSM Director of Technical Marketing, Jean-Claude Tritsch, Ph.D., will present “Why Your Lutein Source Matters” at 9:30 AM on Thursday, October 21st in Sands 105 conference room at the Sands Convention Center. All SupplySide West attendees are welcome to attend.

Standardized crystalline ingredients or plant extracts, such as lutein, are not readily absorbed by the body. Further formulation is required, and lutein ingredient manufacturers use different processes to enrobe the lutein in order for it to be released into the body. Data indicates that these different processes can have a significant impact on the bioavailability of the lutein ingredient and may hinder the bioavailability of the ingredient. Lutein bioavailability—the delivery of the ingredient to the beneficial sites of action - including the macula, where lutein is quantified as macular pigment optical density (“MPOD”) is essential for eye health. Research supports that MPOD has the potential to become a commonly tested biomarker in the assessment of visual function and the risk for eye disease.. Awareness of MPOD and the technology used for its measurement are growing among eye care practitioners and consumers.

FloraGLO Lutein beadlets utilize Actilease® beadlet technology, a branded, patented technology from DSM that formulates FloraGLO Lutein into micro-sized particles that are protected in a water-soluble shell. Published research shows that FloraGLO Lutein, with Actilease® Technology, is clinically proven to be absorbed by the body into the bloodstream and, more importantly, deposited into the macula increasing MPOD. A lutein supplier lacking its own bioavailability data and making structure/function claims based upon clinical studies conducted with other sources of lutein, such as FloraGLO, may not have the required substantiation for claims of product benefits if its lutein is not bioavailable

“It is important for manufacturers to deliver on their promised health benefits on product labeling and formulate with a quality lutein ingredient that can assure delivery to beneficial sites of action,” says Heather Richardson, FloraGLO Product Manager for Kemin Health. “The quality of a supplement brand and its ingredients, such as lutein and zeaxanthin, is critical as doctors are embracing new technology to measure and monitor MPOD levels in their patients,” adds Richardson.

About Kemin – Inspired Molecular Solutions™
Founded in 1961, Kemin Industries, Inc. (kemin.com) provides highly researched and highly effective ingredients with nutrition and health benefits to all levels of the feed and food supply chains as well as to the global health, nutrition and beauty markets. With a specific focus on each market served and with expertise in animal and human physiology, Kemin operates "glocally" in more than 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Singapore, South Africa and the United States. Kemin Health, L.C. is credited with successfully commercializing lutein and significantly developing the eye supplement category under the FloraGLO® Lutein brand (floraglolutein.com), the leading and most researched lutein ingredient brand sold worldwide.

About DSM Nutritional Products
DSM Nutritional Products (dsmnutritionalproducts.com) is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over $2.5 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments.

® ™ Trademarks of Kemin Industries, Inc., U.S.A.
Actilease® is a registered trademark of DSM IP Assets B.V. Ltd.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin and DSM Nutritional Products Present New Bioavailability Study Results on FloraGLO® Lutein with Actilease®

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Erin Hockman / Courtney Schwartz - Kemin.com 
515-559-5349 / 515-559-5123 erin.hockman[.]kemin.com / courtney.schwartz[.]kemin.co
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)